返回ChemicalBook首页>CAS数据库列表>138383-07-0

138383-07-0

中文名称 138383-07-0
英文名称 SQ-31765
CAS 138383-07-0
分子式 C24H27F3N2O4
分子量 464.48
MOL 文件 138383-07-0.mol
138383-07-0 结构式 138383-07-0 结构式

基本信息

中文别名
化合物 T12993
英文别名
2H-1-Benzazepin-2-one, 3-(acetyloxy)-1-[2-(dimethylamino)ethyl]-1,3,4,5-tetrahydro-4-(4-methoxyphenyl)-6-(trifluoromethyl)-, (3R,4S)-

物理化学性质

储存条件-20°C储存
溶解度溶于二甲基亚砜

安全数据

危险性符号(GHS)GHS hazard pictograms
GHS07
警示词警告
危险性描述H302-H315-H319-H335

常见问题列表

生物活性
SQ-31765 是一种钙通道 (calcium channel) 阻断剂。
靶点

Calcium channel

体内研究

SQ-31765 (SQ 31,765) can reduce the severity of ischemia in a manner which is independent of changes in myocardial blood flow or hemodynamic alterations. Anesthetized dogs are given saline (n=6), SQ-31765 (n=6; 0.2 mg/kg) or SQ 32,189 (n=6; 0.2 mg/kg) i.v. 10 min before ischemia. The effect on pacing-induced ST-segment elevation (pacing+left anterior descending coronary artery stenosis) and myocardial blood flow are determined. SQ-31765 reduces ST-elevation (P<0.05) compared to saline at 10, 40 and 70 min after infusion (5.9±1.4 and 12.0±1.4 mV, respectively, at 70 min). Left anterior descending coronary artery stenosis during atrial pacing resulted in a significant reduction in subendocardial flow in all groups before drug infusion (41±7, 44±7 and 35±9 mL/min/100 g for saline, SQ-31765 and SQ 32,189, respectively).

"138383-07-0" 相关产品信息